| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Jan 25 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 110.24 | 1,446 | 159.41 k | 149,378 |
| 29 Nov 24 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 97.76 | 207 | 20.24 k | 150,824 |
| 29 Nov 24 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 96.74 | 1,746 | 168.91 k | 151,031 |
| 29 Nov 24 | BPMC Blueprint Medicines | Common Stock | Sell | Dispose S | No | Yes | 95.4 | 400 | 38.16 k | 152,777 |
| 12 Sep 24 | BCAX Bicara Therapeutics Inc. Common Stock | Stock Option Common Stock | Grant | Acquire A | No | No | 18 | 23,746 | 427.43 k | 23,746 |
| 17 Jun 24 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7 | 30,000 | 210.00 k | 30,000 |
